Location: Home
  • search
  • go
  • Relate News
  • 11/18/2024LeadingTac Secures CNY100M+ in Series A Financing to Advance TPD-Based...
  • 11/18/2024ITabMed Unveils Promising Clinical Data on BsAb A-319 for Severe Refra...
  • 11/18/2024New Report on China's Biopharma Revolution: A Decade of Progress and t...
  • 11/18/2024HCW Bio and WY Bio Enter License and Co-Development Deal
  • 11/18/2024China's Biopharma Boom: A Surge in Innovation and Drug Approvals
  • 11/18/2024CDE Issues the Technical Guidelines for Clinical Pharmacology Research...
  • 11/15/2024NMPA Issues the Interim Rules on Designated Domestic Representatives f...
  • 11/15/2024Recent Executive Moves
  • 11/14/2024AstraZeneca Shifts to U.S. Expansion Amid Ongoing Challenges in China
  • 11/14/2024Lundbeck CEO Optimistic About Vyepti's Market Potential in China Follo...
  • 11/14/2024Sino Biopharma Gains Chinese Approval for Garsorasib for Advanced NSCL...
  • 11/14/2024NHC Holds Forum with Domestic and Foreign Pharma Cos on Compliance Iss...
  • 11/14/2024NHSA Holds Forum on Empowering Commercial Health Insurance with BMI Pl...
  • 11/14/2024CDE Seeks Public Comments on the Supplemental List of External Exper...
  • 11/14/2024BeiGene Rebrands as BeOne Medicines to Reflect Global Mission, Distanc...
  • 11/14/2024Zai Lab Aims to Raise $200M for Global Expansion and Innovative Drug D...
  • 11/14/2024Merck Enters into Global License Deal for LaNova's Anti-PD-1/VEGF BsAb...
  • 11/14/2024Europe's Pharma R&D Falling Behind as US Surges, China Rises
  • 11/14/2024Q3/2024 Performance of Leading MNCs in China: AZ Overtakes MSD as Nova...
  • 11/14/2024Passage to Asia: Early Access for Innovative Therapies (PharmExec)
  • 11/14/2024China on the Move: New Level of Opening up in Health Care Sector (NLR)
  • 11/13/2024How China's Anti-Espionage Law Could Impact Pharmaceutical Supply Chai...
  • 11/13/2024BioNTech to Acquire Biotheus to Boost Oncology Strategy
  • 11/13/2024NMPA Accepts CANbridge Pharma's NDA of CAN103 for Gaucher Disease
  • 11/13/2024Novartis Files NDA of Pluvicto (Lu 177 vipivotide tetraxetan) in China
  • 11/13/2024Shanghai Pharma Considers API Partnerships with Indian Drugmakers amid...
  • 11/12/2024Biocytogen Announces IDEAYA's Nomination of Development Candidate IDE0...
  • 11/12/2024Abbisco Reports Positive Top-line Results from Pivotal Phase 3 MANEUVE...
  • 11/12/2024CStone Presents Promising Preclinical Data for Trispecific Antibody CS...
  • 11/12/2024Eccogene Secures Dual IND Approvals for Once-Daily Oral GLP-1 Receptor...
  • Page:50/786 Total number of articles:23558: [First][<<] [48] [49] [50] [51] [52] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group